Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 836258
                    [Title] => Cilostazol beats aspirin in secondary stroke prevention
                    [Summary] => 
Aspirin has been a popular agent for preventing stroke recurrence of ischemic origin.
                    [DatePublished] => 2012-08-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

COCHRANE STROKE GROUP TRIALS REGISTER

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 836258
                    [Title] => Cilostazol beats aspirin in secondary stroke prevention
                    [Summary] => 
Aspirin has been a popular agent for preventing stroke recurrence of ischemic origin.
                    [DatePublished] => 2012-08-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Cilostazol beats aspirin in secondary stroke prevention

August 9, 2012 - 12:00am

Aspirin has been a popular agent for preventing stroke recurrence of ischemic origin.

Science and Environment